The studies consist of three proteomic experiments. Co-IP coupled mass spectrometry analysis of PRDX2; identification of the potential directed protein targets of biotin-DMY by pull-down coupled MS analysis; Label-free quantitative proteomic analysis of non-senescent and senescent HMC3 cells treated with DMY or Conodin A.